Carregant...
Low lopinavir plasma or hair concentrations explain second line protease inhibitor failures in a resource-limited setting
BACKGROUND: In resource-limited settings, many patients, with no prior PI treatment on a second-line, high genetic barrier, ritonavir boosted protease inhibitor (PI) containing regimen have virologic failure. METHODS: We conducted a cross-sectional survey to investigate the aetiology of virologic fa...
Guardat en:
| Autors principals: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2011
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3073814/ https://ncbi.nlm.nih.gov/pubmed/21239995 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0b013e31820dc0cc |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|